Teva Settles Rhode Island Opioid Claims, Seeks Nationwide Agreement
Generics Giant Will Pay The State $21m Over 13 Years Alongside $78.5m In Products
Teva has settled with the state of Rhode Island on opioid-related claims and is set to pay the state $21m in cash and provide $78.5m worth of Narcan and Suboxone. The settlement was reached just as Rhode Island was preparing to take Teva to trial.
You may also be interested in...
Teva has settled the final outstanding advanced US state-level opioid-related case against the firm, but recent allegations from the New York attorney general could see the firm back in court sooner rather than later.
Teva has struck a further cash-and-medicines settlement agreement to resolve opioid-related claims in the US. A bench trial had been due to start in West Virginia by the end of this month, where Teva is to pay $75m over 15 years plus generic Narcan.
Fresh from inking a settlement agreement in Texas, Teva has seen a motion to stay opioids claims in San Francisco denied. A court in Northern California was not persuaded that a judgment in another part of the state would preclude claims.